Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ
Authors:
Open Access
- 15 May 2013
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 6 (1) , 215-219
Abstract
The incidence rates of cervical adenocarcinoma have been increasing over the last two decades, contrary to those of squamous cell carcinoma. This trend is particularly evident among females aged <40 years and has occurred despite extensive cytology‑based screening programs. The aim of the present retrospective database study was to investigate adenocarcinoma in situ (AIS) with respect to previous cytological results, high‑risk (HR) human papillomavirus (HPV) infections and histological results from AIS‑adjacent squamous mucosa. Databases were used to identify 32 female patients with AIS treated for various conditions between 2009 and 2012 at the Department of Gynecology, Uppsala University Hospital (Uppsala, Sweden) and previous cytological, HPV and histological results. Of the individuals in the study, 64.3% had a previously recorded cytological result showing squamous cell abnormalities; five had glandular cell abnormalities (18%) and two had AIS (7.1%). Among the patients with available HPV results, 95% were HR‑HPV‑positive; HPV18/45 predominated (77%), followed by HPV16 (27%). The patients with multiple HPV infections were aged ≤32 years, while patients aged ≥38 years were only infected with HPV18/45. All but three patients had cervical intraepithelial neoplasia (CIN) in the AIS‑adjacent squamous mucosa, 79% of which was CIN2 or worse. The present retrospective database study suggests that AIS is detected at screening mainly due to simultaneous squamous precursor lesions and that HPV18/45 infection is an increasing co‑factor for AIS in older patients. HPV analyses of glandular precursor lesions aid in the identification of female individuals at risk of progression to invasive disease, and thus have a favorable effect on adenocarcinoma prevention, together with vaccination.Keywords
This publication has 40 references indexed in Scilit:
- Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort studyBMJ, 2009
- Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasiaJournal of Clinical Virology, 2009
- Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent InfectionsJNCI: Journal of the National Cancer Institute, 2008
- Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and PreventionJNCI: Journal of the National Cancer Institute, 2006
- The role of human papillomavirus testing in cervical screeningJournal of Clinical Virology, 2005
- Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for ScreeningObstetrics & Gynecology, 2004
- Adenocarcinoma in situ of the cervix-controversies in diagnosis and treatment.Journal of Lower Genital Tract Disease, 2001
- International trends in incidence of cervical cancer: II. Squamous-cell carcinomaInternational Journal of Cancer, 2000
- Human Papillomavirus DNA in Glandular Dysplasia and Microglandular Hyperplasia: Presumed Precursors of Adenocarcinoma of the Uterine CervixObstetrics & Gynecology, 1989
- Cervical intraepithelial neoplasia.1973